6-146434188-T-C
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_001278064.2(GRM1):āc.2977T>Cā(p.Ser993Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.531 in 1,612,248 control chromosomes in the GnomAD database, including 229,896 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001278064.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRM1 | NM_001278064.2 | c.2977T>C | p.Ser993Pro | missense_variant | 8/8 | ENST00000282753.6 | NP_001264993.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRM1 | ENST00000282753.6 | c.2977T>C | p.Ser993Pro | missense_variant | 8/8 | 1 | NM_001278064.2 | ENSP00000282753.1 |
Frequencies
GnomAD3 genomes AF: 0.568 AC: 86347AN: 151972Hom.: 25163 Cov.: 33
GnomAD3 exomes AF: 0.521 AC: 129672AN: 249042Hom.: 34812 AF XY: 0.525 AC XY: 70692AN XY: 134770
GnomAD4 exome AF: 0.527 AC: 769036AN: 1460160Hom.: 204692 Cov.: 43 AF XY: 0.529 AC XY: 384356AN XY: 726230
GnomAD4 genome AF: 0.568 AC: 86437AN: 152088Hom.: 25204 Cov.: 33 AF XY: 0.564 AC XY: 41909AN XY: 74318
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 15, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2019 | This variant is associated with the following publications: (PMID: 25062106, 24442360) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Autosomal recessive spinocerebellar ataxia 13 Benign:3
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Spinocerebellar ataxia 44 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at